| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.5 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |